FTH

$19.65+2.18%visit website

Sensei Biotherapeutics, Inc.

Market Cap

$508M

Live price × SEC shares (Oct 30, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.15

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

3.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Total operating expenses	4,957	170,627	18,385	22,086	216,055
Operating income	(4,957)	(170,627)	(18,385)	(22,086)	(216,055)
Interest expense	3.00
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(4,717)	(170,236)	(16,007)	(20,398)	(211,358)
EPS (basic) ($)		(131.45)	(2.84)	(0.79)	—
EPS (diluted) ($)		(131.45)	(2.84)	(0.79)	—
Weighted avg. shares (basic)		1,295	5,643	25,841
Weighted avg. shares (diluted)		1,295	5,643	25,841

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 3, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 23 more quarters, back to Mar 2020, with Tormere Pro.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 8:14 AM ET	2.02Earnings release	Document SEC ↗
Oct 27, 2026 accepted 7:33 AM ET	5.02Officer / director change	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

52%

W/W -13.0pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-01	2026-07-01	STEPHENSON BRIAN C	Chief Financial Officer	Purchase	5,000	$23.50	$117K	46.7K	View
2026-06-30	2026-07-01	STEPHENSON BRIAN C	Chief Financial Officer	Purchase	7,803	$24.25	$189K	41.7K	View
2026-06-29	2026-07-01	STEPHENSON BRIAN C	Chief Financial Officer	Purchase	831	$23.34	$19K	33.9K	View
2026-06-26	2026-06-26	STEPHENSON BRIAN C	Chief Financial Officer	Purchase	6,250	$24.95	$156K	33.1K	View
2026-06-24	2026-06-26	STEPHENSON BRIAN C	Chief Financial Officer	Purchase	9,391	$26.13	$245K	26.8K	View

1–5 of 8

1 / 2

Recent News

A family trust receives 100,000 shares as a gift from the CEO of Faeth Therapeutics (FTH).

Stock Titan · 2026-11-04

Faeth Therapeutics Reports Third Quarter 2026 Financial Results and Operational Updates

Yahoo · 2026-11-03

Faeth Therapeutics Q3 EPS $(0.79) Misses $(0.71) Estimate

Benzinga · 2026-11-03

Faeth Appoints Adam Schayowitz, Ph.D., MBA, Head of Research and Development at Zymeworks, to Board of Directors

Yahoo · 2026-10-27

BTIG Reiterates Buy on Faeth Therapeutics, Maintains $55 Price Target

Benzinga · 2026-10-27

Faeth Presents Updated Preclinical Data at ESMO, including First-Ever Head-to-Head Characterization of PIKTOR against Gedatolisib

Yahoo · 2026-10-23

Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo · 2026-10-22

William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage

Yahoo · 2026-10-21

Faeth to Present Preclinical Data on PIKTOR in HR+/HER2- Breast Cancer Models at ESMO 2026

Yahoo · 2026-10-19

William Blair Initiates Coverage On Faeth Therapeutics with Outperform Rating

Benzinga · 2026-10-16

Sensei Biotherapeutics Highlights PIKTOR Strategy Ahead of Endometrial Trial Readout

Yahoo · 2026-10-07

Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors

Yahoo Finance · 2026-09-17

Faeth Therapeutics to Participate in Upcoming September Investor Conferences

Yahoo Finance · 2026-09-01

What Makes Faeth Therapeutics, Inc. (FTH) a Strong Momentum Stock: Buy Now?

Yahoo Finance · 2026-09-01

FT stock picking game results: the unexpected triumph of fundamentals

Financial Times · 2026-08-28

Informational purposes only, not investment advice.

FTH

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Sensei Biotherapeutics, Inc. (FTH)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-07-01	STEPHENSON BRIAN C	P	4,400	$102,960
2026-07-01	STEPHENSON BRIAN C	P	600	$14,532
2026-06-30	STEPHENSON BRIAN C	P	1,910	$43,834.5
2026-06-30	STEPHENSON BRIAN C	P	4,255	$106,289.9
2026-06-30	STEPHENSON BRIAN C	P	1,638	$39,115.44